GlassScriptPhysician profile
Marc I Sandberg
NPI 1770557837
$566,757.13
in general payments reported to CMS, 2019-2025
72 companies · $47K in 2025
The $47K reported for 2025 was more than what 96% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123K · 2020: $83K · 2021: $85K · 2022: $74K · 2023: $71K · 2024: $84K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $169K · Food and Beverage: $11K · Travel and Lodging: $9,457 · Consulting Fee: $7,434 · Honoraria: $4,750 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $169,368.60 |
| Food and Beverage | $10,531.37 |
| Travel and Lodging | $9,457.44 |
| Consulting Fee | $7,433.86 |
| Honoraria | $4,750.00 |
| Education | $254.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $186,921.74 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Sanofi-Aventis U.S. LLC | $148,819.63 | 2019-2025 | |
| Novo Nordisk INC | $110,905.18 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26,995.38 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Valeritas, INC. | $24,822.74 | 2019 | |
| Corcept Therapeutics | $15,549.65 | 2019-2025 | Korlym |
| Astrazeneca Pharmaceuticals LP | $10,353.82 | 2019-2023 | Farxiga |
| Intuity Medical INC | $10,320.37 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Abbvie INC. | $8,079.28 | 2019-2024 | Synthroid |
| Janssen Pharmaceuticals, INC | $6,296.70 | 2019-2020 | |
| Zealand Pharma US, INC. | $3,862.00 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $3,328.74 | 2019-2025 | Unithroid |
| Recordati_rare_diseases_inc. | $2,302.12 | 2021-2025 | Isturisa, Signifor Lar |
| Mannkind Corporation | $1,510.40 | 2019-2025 | Afrezza |
| Amgen INC. | $579.44 | 2019-2025 | Evenity, Prolia, Tepezza |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $477.57 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Dexcom, INC. | $451.43 | 2019-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $365.03 | 2019-2025 | |
| Abbott Laboratories | $342.53 | 2021-2025 | Freestyle Libre |
| Insulet Corporation | $342.14 | 2019-2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $299.81 | 2021-2025 | |
| Radius Health, INC. | $291.76 | 2019-2025 | Tymlos |
| Tandem Diabetes Care, INC. | $268.23 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Xeris Pharmaceuticals, INC. | $249.20 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Amarin Pharma, INC. | $201.49 | 2019-2023 | |
| Medtronic, INC. | $196.91 | 2022-2025 | Minimed 780g, Intellis Adaptivestim |
| Medtronic Minimed, INC. | $189.63 | 2019-2020 | |
| Astellas Pharma US INC | $175.39 | 2024-2025 | Veozah |
| Merck Sharp & Dohme LLC | $132.34 | 2019-2021 | |
| Embecta Corp. | $119.92 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Tolmar, INC. | $113.78 | 2023-2025 | Jatenzo |
| Cequr Corporation | $113.10 | 2022-2025 | Cequr Simplicity |
| Ibsa Pharma INC. | $110.11 | 2019-2025 | Tirosint, Licart, Flector |
| Acella Pharmaceuticals, LLC | $107.94 | 2022-2025 | NP Thyroid 60 |
| Currax Pharmaceuticals LLC | $102.91 | 2021-2024 | Contrave |
| Novartis Pharmaceuticals Corporation | $87.10 | 2023-2025 | |
| Senseonics, Incorporated | $75.00 | 2019 | |
| Lifescan, INC. | $74.18 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $66.50 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $63.56 | 2020-2025 | Strensiq |
| Madrigal Pharmaceuticals | $61.21 | 2024-2025 | Rezdiffra, Resmetirom |
| Esperion Therapeutics, INC. | $59.24 | 2021-2022 | |
| Horizon Therapeutics Plc | $58.04 | 2020-2022 | |
| Clarus Therapeutics INC. | $57.95 | 2021 | |
| Ascendis Pharma Endocrinology INC | $52.42 | 2025 | Yorvipath |
| Neurocrine Biosciences, INC. | $51.66 | 2024-2025 | |
| Kyowa Kirin, INC. | $50.23 | 2023 | Crysvita |
| Companion Medical, INC. | $46.92 | 2019-2020 | |
| Ultragenyx Pharmaceutical INC. | $46.62 | 2021 | |
| Amryt Pharma Holdings LTD | $45.46 | 2022-2023 | Mycapssa |
| Eisai INC. | $44.90 | 2019-2025 | |
| Shire North American Group INC | $43.22 | 2019 | |
| Becton, Dickinson and Company | $43.05 | 2021-2022 | |
| Strongbridge US INC. | $41.28 | 2020 | |
| Soleno Therapeutics, INC. | $34.15 | 2025 | Vykat Xr |
| Vivus LLC | $29.93 | 2019 | |
| Azurity Pharmaceuticals, INC. | $29.76 | 2023-2025 | Azmiro, Adthyza |
| Regeneron Healthcare Solutions, INC. | $28.85 | 2019 | |
| Topcon Healthcare Solutions, INC. | $27.03 | 2020 | |
| Beta Bionics, INC. | $24.79 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Verity Pharmaceuticals INC. | $24.39 | 2024 | Tlando |
| Aytu Biopharma, INC. | $24.16 | 2019-2020 | |
| Halozyme INC | $22.00 | 2023 | |
| Sequel Med Tech, LLC | $18.17 | 2025 | Twiist |
| Acerus Pharmaceuticals Corporation | $17.84 | 2020 | |
| Glaxosmithkline, LLC. | $17.36 | 2025 | Arexvy, Shingrix |
| Globus Medical, INC. | $16.93 | 2025 | Senza |
| Eusa Pharma (US) LLC | $16.84 | 2022 | |
| Amphastar Pharmaceuticals, INC. | $15.92 | 2024 | |
| Nalpropion Pharmaceuticals LLC | $14.99 | 2019 | |
| Sanofi Pasteur INC. | $13.85 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Sandberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.